Combination Approach: the Future of the War Against Cancer

被引:7
作者
Chen, Lan [1 ]
Malhotra, Anshoo [2 ]
机构
[1] Yangtze Univ, Affiliated Hosp 1, Jingzhou, Hubei, Peoples R China
[2] Postgrad Inst Med Educ & Res, Dept Biophys, Chandigarh 160012, India
关键词
Combination approach; Nanoparticles; Cancer; Phytochemicals; ANTI PROLIFERATIVE ACTIVITIES; PHASE-II; PERIOPERATIVE CHEMOTHERAPY; LUNG CARCINOGENESIS; TRIAL; RADIOSENSITIZATION; ANTIOXIDANT; CURCUMIN; SURGERY; DRUG;
D O I
10.1007/s12013-015-0549-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer remains one of the major health problems worldwide and is responsible for one in eight deaths. The worldwide research against cancer as well as genome wide association studies was successful in indentifying the loci associated with cancer but still a substantial amount of casualty remains unexplained. The reason being the cancer cell rapidly develops resistance against the chemotherapeutic or chemopreventive agent in use. Over the last decade, the thorough understanding of molecular and biochemical mechanisms of the carcinogenesis process lead to the rationale of combining anti-cancer agents (therapeutic as well as chemopreventive) to target multiple pathways. Scientists, the world over trying various combinations of chemotherapy, radiation therapy, chemopreventive agents, nanoparticles, etc., in order to specifically as well as efficiently target cancer cells. The present review article summarizes the recent advances in the combination approach against cancer in order to enhance efficacy of treatment with minimal side effects.
引用
收藏
页码:637 / 641
页数:5
相关论文
共 47 条
  • [1] Antioxidant activity of grains
    Adom, KK
    Liu, RH
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2002, 50 (21) : 6182 - 6187
  • [2] 6-mercaptopurine and daunorubicin double drug liposomes - Preparation, drug-drug interaction and characterization
    Agrawal, V
    Paul, MK
    Mukhopadhyay, AK
    [J]. JOURNAL OF LIPOSOME RESEARCH, 2005, 15 (3-4) : 141 - 155
  • [3] Candidate mechanisms for chemotherapy-induced cognitive changes
    Ahles, Tim A.
    Saykin, Andrew J.
    [J]. NATURE REVIEWS CANCER, 2007, 7 (03) : 192 - 201
  • [4] Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy
    Bansal, Tripta
    Jaggi, Manu
    Khar, Roop K.
    Talegaonkar, Sushama
    [J]. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2009, 12 (01): : 46 - 78
  • [5] STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM
    BAZILE, D
    PRUDHOMME, C
    BASSOULLET, MT
    MARLARD, M
    SPENLEHAUER, G
    VEILLARD, M
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) : 493 - 498
  • [6] Brenner DE, 2000, J CELL BIOCHEM, P121
  • [7] Antioxidant and anti proliferative activities of common vegetables
    Chu, YF
    Sun, J
    Wu, XZ
    Liu, RH
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2002, 50 (23) : 6910 - 6916
  • [8] Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
    Constantinou, Constantina
    Papas, Andreas
    Constantinou, Andreas I.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (04) : 739 - 752
  • [9] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Cunningham, David
    Allum, William H.
    Stenning, Sally P.
    Thompson, Jeremy N.
    Van de Velde, Cornelis J. H.
    Nicolson, Marianne
    Scarffe, J. Howard
    Lofts, Fiona J.
    Falk, Stephen J.
    Iveson, Timothy J.
    Smith, David B.
    Langley, Ruth E.
    Verma, Monica
    Weeden, Simon
    Chua, Yu Jo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) : 11 - 20
  • [10] Davis CD, 2007, EXP BIOL MED, V232, P176